AbbVie Inc. FDA Record
- Latest inspection NAI · Apr 27, 2026
- No warning letters matched by name
AbbVie Inc. has 20 FDA recalls, 52 inspections, 7 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "AbbVie Inc." is on file.
- Latest recall
- D-0551-2026 · Class III · May 18, 2026
- Latest inspection
- Apr 27, 2026 · NAI
- Latest 510(k)
- Jan 16, 2026
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 20 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 7 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 52 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
AbbVie Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 3 | 0 | 0 | 1 | 0 |
| 2025 | 3 | 0 | 0 | 0 | 0 |
| 2024 | 3 | 0 | 0 | 2 | 0 |
| 2023 | 2 | 0 | 0 | 1 | 0 |
| 2022 | 2 | 0 | 0 | 0 | 0 |
| 2021 | 1 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 6 | 0 | 0 | 1 | 0 |
| 2017 | 1 | 0 | 0 | 6 | 0 |
Reviewing AbbVie Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check AbbVie Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0551-2026 | Class III | PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only… | May 18, 2026 |
| D-0665-2024 | Class II | Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Ointment, Net wt, 0.12… | Sep 16, 2024 |
| D-0664-2024 | Class II | Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz… | Sep 16, 2024 |
| D-0088-2024 | Class III | Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc… | Oct 17, 2023 |
| D-0412-2018 | Class III | Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North… | Jan 22, 2018 |
| D-0034-2018 | Class III | AndroGel (testosterone gel) 1.62%, 40.5mg in 2.5g aluminum foil packet, 30 Packets per carton. Rx… | Sep 8, 2017 |
| D-0033-2018 | Class III | AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump… | Sep 8, 2017 |
| Z-2177-2017 | Class II | AbbVie PEG, PEG Kit 15FR, FOR ENTERAL USE ONLY, STERILE, Rx Only. | Apr 27, 2017 |
| Z-2176-2017 | Class II | AbbVie PEG, PEG Kit 20FR, FOR ENTERAL USE ONLY, STERILE, Rx Only. | Apr 27, 2017 |
| Z-2178-2017 | Class II | AbbVie PEG, PEG Kit 15FR, FOR ENTERAL USE ONLY, STERILE, Rx Only. | Apr 27, 2017 |
| D-0495-2017 | Class II | Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7… | Jan 13, 2017 |
| Z-0786-2017 | Class II | AbbVie PEG Kit 20 FR | Nov 22, 2016 |
| D-0833-2016 | Class III | Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago… | Mar 24, 2016 |
| D-1611-2014 | Class II | CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx… | Sep 15, 2014 |
| D-1288-2014 | Class II | Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled… | Mar 10, 2014 |
| D-1291-2014 | Class II | Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled… | Mar 10, 2014 |
| D-1289-2014 | Class II | LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with… | Mar 10, 2014 |
| D-1287-2014 | Class II | Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled… | Mar 10, 2014 |
| D-1290-2014 | Class II | Lupron Depot (leuprolide acetate for depot suspension) Single Dose Administration Kit with prefilled… | Mar 10, 2014 |
| D-901-2013 | Class III | Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical… | Aug 1, 2013 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 27, 2026 | North Chicago, IL | Drugs | No Action Indicated (NAI) | 3009751352 |
| Apr 2, 2026 | North Chicago, IL | Drugs | No Action Indicated (NAI) | 3009751352 |
| Mar 3, 2026 | North Chicago, IL | Drugs | No Action Indicated (NAI) | 1411365 |
| Aug 21, 2025 | North Chicago, IL | Drugs | No Action Indicated (NAI) | 3009751352 |
| Jun 12, 2025 | North Chicago, IL | Biologics | No Action Indicated (NAI) | 3009751352 |
| Jan 24, 2025 | Aprilia, Italy | Drugs | Voluntary Action Indicated (VAI) | 3002806277 |
| Jun 18, 2024 | North Chicago, IL | Drugs | Voluntary Action Indicated (VAI) | 1411365 |
| Apr 19, 2024 | North Chicago, IL | Drugs | No Action Indicated (NAI) | 3009751352 |
| Apr 18, 2024 | Barceloneta, PR | Drugs | Voluntary Action Indicated (VAI) | 3000210838 |
| May 12, 2023 | Wyandotte, MI | Drugs | No Action Indicated (NAI) | 3010166391 |
| Jan 31, 2023 | North Chicago, IL | Drugs | Voluntary Action Indicated (VAI) | 3009751352 |
| Oct 6, 2022 | North Chicago, IL | Drugs | No Action Indicated (NAI) | 3009751352 |
| May 20, 2022 | Aprilia, Italy | Drugs | Voluntary Action Indicated (VAI) | 3002806277 |
| Dec 15, 2021 | North Chicago, IL | Drugs | Voluntary Action Indicated (VAI) | 3009751352 |
| Feb 20, 2020 | Barceloneta, PR | Drugs | Voluntary Action Indicated (VAI) | 3000210838 |
| Feb 15, 2019 | North Chicago, IL | Drugs | No Action Indicated (NAI) | 3009751352 |
| Dec 21, 2018 | Barceloneta, PR | Drugs | No Action Indicated (NAI) | 3000210838 |
| Nov 16, 2018 | North Chicago, IL | Drugs | No Action Indicated (NAI) | 3009751352 |
| Nov 15, 2018 | Aprilia, Italy | Devices | No Action Indicated (NAI) | 3002806277 |
| Aug 24, 2018 | North Chicago, IL | Drugs | No Action Indicated (NAI) | 1411365 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3009751352 | North Chicago, IL | 20 | Apr 27, 2026 |
| FEI 1411365 | North Chicago, IL | 10 | Mar 3, 2026 |
| FEI 3002806277 | Aprilia, Italy | 6 | Jan 24, 2025 |
| FEI 3000210838 | Barceloneta, PR | 9 | Apr 18, 2024 |
| FEI 3010166391 | Wyandotte, MI | 6 | May 12, 2023 |
| FEI 3010757606 | North Chicago, IL | 1 | Dec 16, 2014 |
AbbVie Inc. and the FDA: common questions
Has AbbVie Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "AbbVie Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has AbbVie Inc. received an FDA Form 483?
FDA has not published a Form 483 for "AbbVie Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect AbbVie Inc.?
The most recent FDA inspection on file ended Apr 27, 2026 at North Chicago, IL and was classified NAI. FDA has 52 inspections of AbbVie Inc. on file.
Has AbbVie Inc. had an FDA recall?
Yes. AbbVie Inc. has 20 FDA recalls on record. The most recent started May 18, 2026.
Need more than this page shows? Ask about AbbVie Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.